Autonomix Medical, Inc. · NASDAQ:AMIX

Autonomix Medical, Inc. financial statements

Autonomix Medical, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022
Revenue0000
Cost of revenue12.0K183.0K81.0K
Gross profit-12.0K-183.0K-81.0K
Research and development7.14M4.72M2.23M745.0K4.07K
Selling, general and administrative9.89M6.86M5.25M1.25M13.6M
Operating income-17.0M-11.6M-12.0M-1.99M-13.6M
Depreciation and amortization12.0K183.0K81.0K013.6M
EBITDA-17.0M-11.4M-11.9M-1.99M0
Interest expense0176.0K79.0K0218.1K
Income before tax-16.7M-11.4M-15.4M-1.99M-13.3M
Income tax0000-13.6M
Net income-16.7M-11.4M-15.4M-1.99M-13.3M
Earnings per share, basic-2.32-6.46-14.82-0.17-297.87

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022
Cash and equivalents7.00M9.14M8.61M865.0K2.04M
Current assets7.58M9.61M9.39M865.0K2.05M
Property, plant and equipment19.0K21.0K16.0K0
Total assets7.60M9.81M9.41M865.0K2.05M
Accounts payable700.0K676.0K492.0K173.0K91.6K
Current liabilities1.71M1.71M777.0K221.0K93.2K
Long-term debt1.00M
Total debt1.00M0
Total liabilities1.71M1.71M1.78M221.0K93.2K
Shareholders' equity5.89M8.10M7.63M644.0K1.96M
Shares outstanding542.3K2.50M942.6K12.3M44.7K

Cash flow

LineFY2026FY2025FY2024FY2023FY2022
Cash from operations-12.3M-8.26M-6.60M-1.85M-387.3K
Capital spending-10.0K-14.0K-19.0K0-3
Free cash flow-12.3M-8.27M-6.62M-1.85M-387.3K
Cash from investing-10.0K-14.0K-19.0K0
Cash from financing10.2M8.80M14.4M675.0K2.43M
Change in cash-2.13M528.0K7.74M-1.18M2.04M